HNI Stock Analysis: HNI | NYSE
Furnishings, Fixtures & Appliances | NYSE, USA | Market Cap: 2.909m USD | 12M Return: -18.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 28.3M
EPS Trend: 90.3%
Qual. Beats: 0
Rev. Trend: 79.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
HNI Corporation is a U.S.-based manufacturer operating two business segments: Workplace Furnishings and Residential Building Products. The Workplace Furnishings segment produces a broad range of office and commercial furniture - including panel systems, seating, tables, storage, architectural products, and hospitality lines - distributed through independent and company-owned dealers, office product distributors, and direct sales to corporations and government entities. The Residential Building Products segment manufactures gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and outdoor hearth products, sold through a national network of independent dealers and distributors as well as company-owned retail and installation outlets. The company markets products under a large portfolio of brands, including HON, Kimball, Allsteel, Gunlocke, HBF, and National, and is headquartered in Muscatine, Iowa, having been incorporated in 1944.
The workplace furnishings industry is closely tied to corporate real estate spending, office occupancy rates, and broader business investment cycles, while the residential hearth business is driven by housing starts, remodeling activity, and consumer discretionary spending. HNIs combined business model spans both the commercial and consumer sides of the home and office environment, with most revenue generated in the United States and Canada.
- Workplace furnishings demand weakens as return-to-office stalls
- Residential fireplace sales pressured by cooling housing market
- Input cost inflation and pricing competition squeeze operating margins
| Net Income: 1.40m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -9.95 > 1.0 |
| NWC/Revenue: 10.06% < 20% (prev 3.37%; Δ 6.69% < -1%) |
| CFO/TA 0.02 > 3% & CFO 91.9m > Net Income 1.40m |
| Net Debt (1.93b) to EBITDA (222.4m): 8.69 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.1m) vs 12m ago -1.88% < -2% |
| Gross Margin: 38.73% > 18% (prev 39.91%; Δ -1.18% > 0.5%) |
| Asset Turnover: 108.2% > 50% (prev 136.6%; Δ -28.41% > 0%) |
| Interest Coverage Ratio: 1.33 > 6 (EBIT TTM 65.6m / Interest Expense TTM 49.4m) |
| A: 0.08 (Total Current Assets 1.30b - Total Current Liabilities 936.1m) / Total Assets 4.77b |
| B: 0.11 (Retained Earnings 526.5m / Total Assets 4.77b) |
| C: 0.02 (EBIT TTM 65.6m / Avg Total Assets 3.32b) |
| D: 0.59 (Book Value of Equity 1.77b / Total Liabilities 3.00b) |
| Altman-Z'' = 1.61 = BB |
| DSRI: 1.66 (Receivables 555.7m/237.3m, Revenue 3.59b/2.54b) |
| GMI: 1.03 (GM 39.91% / 38.73%) |
| AQI: 1.23 (AQ_t 0.45 / AQ_t-1 0.37) |
| SGI: 1.41 (Revenue 3.59b / 2.54b) |
| TATA: -0.02 (NI 1.40m - CFO 91.9m) / TA 4.77b) |
| Beneish M = -2.02 (Cap -4..+1) = BB |
As of July 09, 2026, the stock is trading at USD 40.28 with a total of 519,585 shares traded. Over the past week, the price has changed by +0.95%, over one month by +28.40%, over three months by +26.02% and over the past year by -18.63%.
Current recommended Stop Loss: 36.00 (which is 10.6% or 2.8 ATR below the current price).
HNI has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy HNI.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 69 | 71.3% |
P/E Trailing = 149.6667
P/E Forward = 10.1112
P/S = 0.8111
P/B = 1.6403
P/EG = 0.5058
Revenue TTM = 3.59b USD
EBIT TTM = 65.6m USD
EBITDA TTM = 222.4m USD
Long Term Debt = 1.43b USD (from longTermDebt, last quarter)
Short Term Debt = 87.0m USD (from shortTermDebt, last quarter)
Debt = 2.01b USD (from shortLongTermDebtTotal, last quarter) + Leases 282.5m
Net Debt = 1.93b USD (calculated: Debt 2.01b - CCE 78.2m)
Enterprise Value = 4.84b USD (2.91b + Debt 2.01b - CCE 78.2m)
Interest Coverage Ratio = 1.33 (Ebit TTM 65.6m / Interest Expense TTM 49.4m)
EV/FCF = 620.7x (Enterprise Value 4.84b / FCF TTM 7.80m)
FCF Yield = 0.16% (FCF TTM 7.80m / Enterprise Value 4.84b)
FCF Margin = 0.22% (FCF TTM 7.80m / Revenue TTM 3.59b)
Net Margin = 0.04% (Net Income TTM 1.40m / Revenue TTM 3.59b)
Gross Margin = 38.73% ((Revenue TTM 3.59b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 34.60% (prev 39.88%)
Tobins Q-Ratio = 1.01 (Enterprise Value 4.84b / Total Assets 4.77b)
Interest Expense / Debt = 2.46% (Interest Expense 49.4m / Debt 2.01b)
Taxrate = 40.20% (36.5m / 90.8m)
NOPAT = 39.2m (EBIT 65.6m * (1 - 40.20%))
Current Ratio = 1.39 (Total Current Assets 1.30b / Total Current Liabilities 936.1m)
Debt / Equity = 1.13 (Debt 2.01b / totalStockholderEquity, last quarter 1.77b)
Debt / EBITDA = 8.69 (Net Debt 1.93b / EBITDA 222.4m)
Debt / FCF = 247.7 (Net Debt 1.93b / FCF TTM 7.80m)
Total Stockholder Equity = 1.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.04% (Net Income 1.40m / Total Assets 4.77b)
RoE = 0.11% (Net Income TTM 1.40m / Total Stockholder Equity 1.31b)
RoCE = 2.39% (EBIT 65.6m / Capital Employed (Equity 1.31b + L.T.Debt 1.43b))
RoIC = 1.02% (NOPAT 39.2m / Invested Capital 3.85b)
WACC = 5.98% (E(2.91b)/V(4.92b) * Re(9.09%) + D(2.01b)/V(4.92b) * Rd(2.46%) * (1-Tc(0.40)))
Discount Rate = 9.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -45.35 | Cagr: -0.56%
[DCF] Terminal Value 73.10% ; FCFF base≈79.8m ; Y1≈70.0m ; Y5≈56.6m
[DCF] Fair Price = N/A (negative equity: EV 908.0m - Net Debt 1.93b = -1.02b; debt exceeds intrinsic value)
EPS Correlation: 90.25 | EPS CAGR: 19.59% | SUE: 0.48 | # QB: 0
Revenue Correlation: 79.83 | Revenue CAGR: 11.15% | SUE: -0.37 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.04 | Chg30d=+0.00% | Revisions=-29% | Analysts=4
EPS next Quarter (2026-09-30): EPS=1.31 | Chg30d=+0.00% | Revisions=-57% | Analysts=4
EPS current Year (2026-12-31): EPS=4.02 | Chg30d=+0.00% | Revisions=-29% | GrowthEPS=+16.3% | GrowthRev=+111.3%
EPS next Year (2027-12-31): EPS=4.83 | Chg30d=+0.00% | Revisions=-17% | GrowthEPS=+20.2% | GrowthRev=+4.0%
[Analyst] Revisions Ratio: -50% (up=3, down=12)